# The Anti-Inflammatory And Metabolic Effects Of Rosiglitazone In Subjects With Rheumatoid Arthritis

> **NCT00379600** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 96 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** rosiglitazone XR

## Key facts

- **NCT ID:** NCT00379600
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2016-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00379600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00379600, "The Anti-Inflammatory And Metabolic Effects Of Rosiglitazone In Subjects With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT00379600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*